{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":5,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":5,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"9d1c7172ce5d","filters":{"venue":"FarFar - Pharmacy Repository"}},"results":[{"id":"W7132956291","doi":"","title":"Structural analysis of PEGylated nanoemulsions using EPR spectroscopy – the impact of an active compound incorporated in stabilizing layer","year":2023,"lang":"en","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Proteins in Food Systems","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Homogenizer; Bioavailability; Drug delivery; Polyvinyl alcohol; Phospholipid; Aqueous solution; Aqueous two-phase system; PEG ratio","authors":[{"name":"Jelena Đoković","is_ca":false},{"name":"Sotiria Demisli","is_ca":false},{"name":"Vassiliki Papadimitriou","is_ca":false},{"name":"Snežana Savić","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09693790705801955,"gpt":0.3679130291362785,"spread":0.2709751220782589,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001746402,0.0002492539,0.0001118662,0.0002043621,0.00009588236,0.0001219658,0.0001296432,0.0002011828,0.0007451916],"category_scores_gemma":[0.0002048369,0.00008457812,0.0001952313,0.0001333344,0.0001579996,0.0002455471,0.00009251283,0.000318502,0.0001959725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001127893,"about_ca_system_score_gemma":0.00008079819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004190309,"about_ca_topic_score_gemma":0.0003848172,"domain_scores_codex":[0.999931,0.000007643502,0.00001019504,0.00001881197,0.00002139508,0.0000110035],"domain_scores_gemma":[0.9998347,0.00003121228,0.00005909897,0.000007877653,0.00004884994,0.00001822481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00004756796,0.0000101476,0.00009010831,0.00002438954,0.000002558996,0.000016656,0.00001665209,0.00005551153,0.9991524,0.00001712288,0.000009770159,0.0005571758],"study_design_scores_gemma":[0.00000391196,0.0001879779,0.00191952,0.000004813271,0.000007092567,0.00004113918,0.00002290657,0.0007066331,0.996648,0.00001677115,0.000436264,0.000004960399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946098,0.000967081,0.003254815,0.0000495242,0.00002522578,0.00002760091,0.0003178992,0.00003909901,0.0007088249],"genre_scores_gemma":[0.9914408,0.001009525,0.005193811,0.00004656575,0.000007118772,0.00004336309,0.0005507292,0.00002838499,0.001679712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007451916,"threshold_uncertainty_score":0.002492845,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7133016376","doi":"","title":"A proposal of innovative injectability assessment method for intravenous formulations - case study on PEGylated nanoemulsions","year":2022,"lang":"en","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Homogenizer; Biocompatibility; Drug delivery; Compounding; Dosage form; Aqueous two-phase system; Critical quality attributes","authors":[{"name":"Jelena Đoković","is_ca":false},{"name":"Sanela Savić","is_ca":false},{"name":"Nebojša Cekić","is_ca":false},{"name":"Snežana Savić","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1308664773748046,"gpt":0.5091508657235977,"spread":0.3782843883487931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001688798,0.0007478377,0.0004994012,0.0012648,0.0003298605,0.001229808,0.0008004797,0.001572114,0.00142289],"category_scores_gemma":[0.00130445,0.0002912137,0.0006208644,0.0005996235,0.0005430101,0.001322263,0.0005326797,0.0006006406,0.000530041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005173272,"about_ca_system_score_gemma":0.0004172012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005033152,"about_ca_topic_score_gemma":0.0005422884,"domain_scores_codex":[0.9990671,0.0001950008,0.00006516775,0.0001648635,0.0004589747,0.00004890433],"domain_scores_gemma":[0.9994504,0.00015743,0.00007850418,0.00005259785,0.0002288205,0.00003219418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003502778,0.0003896325,0.003151266,0.001460442,0.00003732698,0.002775169,0.0005414351,0.009802234,0.6425583,0.009170664,0.002148422,0.3276148],"study_design_scores_gemma":[0.0000402571,0.001593954,0.002782831,0.0001864547,0.0001061147,0.005509914,0.0003015101,0.1100965,0.8243068,0.003308726,0.05161441,0.0001525303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.1035802,0.009823566,0.8681434,0.001188891,0.0002680979,0.001692802,0.0002061766,0.001287312,0.01380967],"genre_scores_gemma":[0.3710183,0.007290108,0.6084771,0.0001944495,0.0001286987,0.0004722892,0.0001667309,0.0001159845,0.01213636],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.001688798,"threshold_uncertainty_score":0.008931279,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7132860175","doi":"","title":"Biocompatible nanoemulsions as a tool for preclinical testing of CW-02-79, a pyrazoloquinolinone modulator of sigma-2 receptors: preformulation and formulation studies","year":2023,"lang":"en","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biocompatible material; In vivo; Receptor; In vitro; Drug discovery; Preclinical testing","authors":[{"name":"Tanja Ilić","is_ca":false},{"name":"Tijana Stanković","is_ca":false},{"name":"Jelena Mitrović","is_ca":false},{"name":"Ivana Pantelić","is_ca":false},{"name":"James M. Cook","is_ca":false},{"name":"Snežana Savić","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08510945275508523,"gpt":0.3928485805724067,"spread":0.3077391278173214,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004662928,0.000406315,0.000204435,0.0002455548,0.0001031646,0.0001758542,0.0001751794,0.0002932876,0.0005167407],"category_scores_gemma":[0.0002136206,0.0000962631,0.000199901,0.0001433948,0.0002100282,0.0002056159,0.0001275181,0.0003946134,0.000199731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000243741,"about_ca_system_score_gemma":0.0001699322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000431819,"about_ca_topic_score_gemma":0.0005358081,"domain_scores_codex":[0.9998862,0.00001442094,0.00001473252,0.00002445876,0.0000425881,0.00001761866],"domain_scores_gemma":[0.9998823,0.00002100076,0.00004541203,0.000009492273,0.00002763897,0.00001404302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003187233,0.00003432739,0.00003409532,0.0000582692,0.000002078089,0.00002204345,0.00001178179,0.00009400071,0.9984038,0.00004610546,0.00001691787,0.001244671],"study_design_scores_gemma":[0.0000102981,0.001079356,0.0003333504,0.000007752992,0.00001139051,0.00005566999,0.000008002808,0.0003573717,0.9967254,0.0000166006,0.001391013,0.000003632857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.970857,0.004798796,0.02159765,0.00007846224,0.00006213685,0.0005350942,0.0005462194,0.0001256557,0.001398949],"genre_scores_gemma":[0.9707144,0.004172218,0.02211532,0.00006038491,0.00002346759,0.0003902648,0.0004756809,0.00003113402,0.002017159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0005167407,"threshold_uncertainty_score":0.002465963,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7132617467","doi":"","title":"Komparativna analiza promene sistema za refundaciju lekova i politike cena lekova u zemljama EU","year":2006,"lang":"","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Regional Development and Management Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"European union; European commission; Mercantilism; Quarter (Canadian coin)","authors":[{"name":"A. Božović-Marković","is_ca":false},{"name":"Guenka Petrova","is_ca":false},{"name":"Ljiljana Tasić","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04510589546980879,"gpt":0.2550810434584335,"spread":0.2099751479886247,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005080651,0.0003319716,0.0007721798,0.003558975,0.0007073942,0.0071679,0.0006661628,0.0006727854,0.01938935],"category_scores_gemma":[0.01820468,0.00030889,0.0006941765,0.008336239,0.0008550659,0.003051954,0.00217101,0.001073362,0.00241513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001973868,"about_ca_system_score_gemma":0.002165708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01659,"about_ca_topic_score_gemma":0.01343838,"domain_scores_codex":[0.9966373,0.001289623,0.0003150754,0.0006069848,0.0007870159,0.0003639128],"domain_scores_gemma":[0.9897379,0.005655441,0.00171134,0.000941538,0.001672843,0.0002808658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001331835,0.0004764273,0.4929556,0.001494519,0.0008151592,0.0006316991,0.01556051,0.01157528,0.002283333,0.101554,0.03070378,0.3406179],"study_design_scores_gemma":[0.0001093257,0.0008600222,0.6967059,0.000782064,0.0008775531,0.0004117204,0.02940774,0.02305374,0.006568728,0.06792755,0.1731613,0.0001343889],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8617141,0.006667051,0.02132366,0.004233309,0.0001175395,0.0002145783,0.009339697,0.0004190131,0.09597111],"genre_scores_gemma":[0.9733598,0.00174654,0.006417769,0.0001758433,0.00004252325,0.0001047785,0.003659377,0.0001577099,0.01433566],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01938935,"threshold_uncertainty_score":0.06486386,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7132978064","doi":"","title":"Meta-analysis of the data on differences in the exposure to psychiatric drugs between poor and normal cYP2C19/CYP2D6 metabolizers","year":2022,"lang":"sr","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"CYP2C19; Pharmacogenetics; Psychosis; Significant difference","authors":[{"name":"F. Milosavljević","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2470309766629272,"gpt":0.42380895361854,"spread":0.1767779769556129,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01649188,0.002626939,0.01294233,0.00401147,0.0008217749,0.00335028,0.001662155,0.001858077,0.005150878],"category_scores_gemma":[0.04274759,0.001278498,0.05289447,0.005913835,0.0005696592,0.001430561,0.001498913,0.002782607,0.0005050275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00154629,"about_ca_system_score_gemma":0.002065289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004880609,"about_ca_topic_score_gemma":0.007779281,"domain_scores_codex":[0.9845861,0.008039056,0.003445268,0.002205872,0.001333214,0.0003904692],"domain_scores_gemma":[0.9713413,0.02159173,0.002843405,0.002495167,0.001457152,0.0002712473],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003199278,0.00002330248,0.01295317,0.0403455,0.9327238,0.0001360024,0.00005269577,0.0006458689,0.0003931271,0.0002041912,0.001008229,0.008314888],"study_design_scores_gemma":[0.0005369209,0.0002189295,0.01160132,0.002635164,0.9813328,0.0001334914,0.00003198735,0.0002600557,0.0002274807,0.0005171656,0.002485297,0.00001937976],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.03526069,0.9461527,0.007428303,0.001046587,0.001210796,0.0005429301,0.006495321,0.0001757054,0.001686877],"genre_scores_gemma":[0.7209182,0.2535214,0.01035751,0.002901442,0.0009015767,0.002064071,0.007024674,0.0002699776,0.002041088],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01649188,"threshold_uncertainty_score":0.0872184,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}